Two stop gain mutations in CEACAM4 were associated with African American breast cancer (Table 3 and Figure 3), and two splicing mutations were associated with European American breast cancer, one in CEACAM6 and another within CEACAM8 (Table 3 and Figure 4). This evidence concerns the gene CEACAM8 and breast carcinoma.